Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -59.87% is in line with its 5-year average of -61.27%, near the low end of its 5-year range (-592.71%–4572.26%).
9.79% above its 12-month average of -66.36%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -94.16%.
NET PROFIT MARGIN
-59.87%
NET PROFIT MARGIN AVG TTM
-66.36%
NET PROFIT MARGIN AVG 3Y
-54.58%
NET PROFIT MARGIN AVG 5Y
-61.27%
NET PROFIT MARGIN AVG 10Y
-314.32%
NET PROFIT MARGIN AVG 15Y
-267.48%
NET PROFIT MARGIN AVG 20Y
-413.40%
CURRENT VS TTM AVG
+9.79%
CURRENT VS 3Y AVG
-9.69%
CURRENT VS 5Y AVG
+2.29%
CURRENT VS 10Y AVG
+80.95%
CURRENT VS 15Y AVG
+77.62%
CURRENT VS 20Y AVG
+85.52%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-22926.92%
vs the sector median at left
Novavax, Inc.
Market Cap
$1.86B
Net Profit Margin
-59.87%
TTM Avg
-66.36%
3Y Avg
-54.58%
5Y Avg
-61.27%
Market Cap
$1.87B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.85B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$1.89B
Net Profit Margin
49.06%
TTM Avg
-18.57%
3Y Avg
-80.13%
5Y Avg
-53.74%
Market Cap
$1.84B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-32.12%
5Y Avg
-45.68%
Market Cap
$1.89B
Net Profit Margin
-404.00%
TTM Avg
-118.68%
3Y Avg
-90.84%
5Y Avg
-270.15%
Market Cap
$1.83B
Net Profit Margin
1.05%
TTM Avg
1.42%
3Y Avg
2.79%
5Y Avg
2.28%
Market Cap
$1.89B
Net Profit Margin
-418.24%
TTM Avg
540.96%
3Y Avg
-464.63%
5Y Avg
-309.76%
Market Cap
$1.83B
Net Profit Margin
-6.93%
TTM Avg
-10.04%
3Y Avg
-34.65%
5Y Avg
-50.14%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novavax, Inc. (NVAX) | $1.86B | -59.87% | -66.36% | -54.58% | -61.27% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | 0.00% | 0.00% | 0.00% | 0.00% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 49.06% | -18.57% | -80.13% | -53.74% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 0.00% | 0.00% | -32.12% | -45.68% |
| Zymeworks Inc. (ZYME)vs › | $1.89B | -404.00% | -118.68% | -90.84% | -270.15% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.05% | 1.42% | 2.79% | 2.28% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -418.24% | 540.96% | -464.63% | -309.76% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -6.93% | -10.04% | -34.65% | -50.14% |
| Azenta, Inc. (AZTA)vs › | $1.81B | -20.02% | -19.08% | -29.38% | -13.21% |
Operating Margin
50.1%
Net Profit Margin
-59.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -94.16% |
| 2026-03-31 | -6.80% |
| 2025-12-31 | 11.91% |
| 2025-09-30 | -287.29% |
| 2025-06-30 | 44.52% |
| 2025-03-31 | 77.80% |
| 2024-12-31 | -91.76% |
| 2024-09-30 | -143.53% |
| 2024-06-30 | 39.08% |
| 2024-03-31 | -157.21% |
| 2023-12-31 | -61.23% |
| 2023-09-30 | -592.71% |
| 2023-06-30 | 13.67% |
| 2023-03-31 | 4572.26% |
| 2022-12-31 | -63.32% |
| 2022-09-30 | -22.95% |
| 2022-06-30 | -274.57% |
| 2022-03-31 | 33.64% |
| 2021-12-31 | 116.49% |
| 2021-09-30 | -180.29% |
| 2021-06-30 | -118.22% |
| 2021-03-31 | -49.80% |
| 2020-12-31 | -63.49% |
| 2020-09-30 | -125.66% |
| 2020-06-30 | -49.30% |
| 2020-03-31 | -765.89% |
| 2019-12-31 | -361.05% |
| 2019-09-30 | -719.70% |
| 2019-06-30 | -1179.71% |
| 2019-03-31 | -1085.33% |
| 2018-12-31 | -805.19% |
| 2018-09-30 | -576.21% |
| 2018-06-30 | -413.00% |
| 2018-03-31 | -480.18% |
| 2017-12-31 | -488.31% |
| 2017-09-30 | -534.09% |
| 2017-06-30 | -660.50% |
| 2017-03-31 | -772.08% |
| 2016-12-31 | -1057.77% |
| 2016-09-30 | -2050.57% |
| 2016-06-30 | -3167.70% |
| 2016-03-31 | -1831.48% |
| 2015-12-31 | -1346.42% |
| 2015-09-30 | -507.59% |
| 2015-06-30 | -147.48% |
| 2015-03-31 | -246.73% |
| 2014-12-31 | -469.16% |
| 2014-09-30 | -240.16% |
| 2014-06-30 | -216.30% |
| 2014-03-31 | -185.07% |
| 2013-12-31 | -160.65% |
| 2013-09-30 | -318.62% |
| 2013-06-30 | -357.77% |
| 2013-03-31 | -260.79% |
| 2012-12-31 | -175.97% |
| 2012-09-30 | -125.19% |
| 2012-06-30 | -83.35% |
| 2012-03-31 | -158.04% |
| 2011-12-31 | -63.39% |
| 2011-09-30 | -64.14% |
| 2011-06-30 | -166.38% |
| 2011-03-31 | -893.65% |
| 2010-12-31 | -8850.98% |
| 2010-09-30 | -5917.14% |
| 2010-06-30 | -134657.14% |
| 2010-03-31 | -10374.55% |
| 2009-12-31 | -18858.11% |
| 2009-09-30 | -3746.27% |
| 2009-06-30 | -29448.28% |
| 2009-03-31 | -39757.14% |
| 2008-12-31 | -15828.57% |
| 2008-09-30 | -4042.27% |
| 2008-06-30 | -2740.35% |
| 2008-03-31 | -1693.23% |
| 2007-12-31 | 1465.34% |
| 2007-09-30 | -681.83% |
| 2007-06-30 | -5186.08% |
| 2007-03-31 | -1255.69% |
| 2006-12-31 | -456.08% |
| 2006-09-30 | -420.28% |
| 2006-06-30 | -764.12% |
| 2006-03-31 | -421.72% |
| 2005-12-31 | 274.29% |
| 2005-09-30 | -146.06% |
| 2005-06-30 | -246.91% |
| 2005-03-31 | -923.70% |
| 2004-12-31 | -502.88% |
| 2004-09-30 | -406.89% |
| 2004-06-30 | -256.81% |
| 2004-03-31 | -163.29% |
| 2003-12-31 | -76.16% |
| 2003-09-30 | -78.73% |
| 2003-06-30 | -221.01% |
| 2003-03-31 | -485.93% |
| 2002-12-31 | -302.83% |
| 2002-09-30 | -272.15% |
